in this issue
World News and Views :: Top of the News
Verenium: Analyst Highlights Risk of Plant Delay
10:20 AM MDT | June 8, 2009 | Alex Scott
Verenium (Cambridge, MA) a biotech start up, faces the risk of a delay in the construction of its planned commercial cellulosic ethanol facility as well as risks to its enzymes business, says Laurence Alexander, an analyst with Jefferies & Co. (New York), in a recent report. Alexander suggests that when looking at Verenium as an investment option, that there are “better risk-rewards available elsewhere.” Alexander’s report follows a recent meeting with Verenium’s president and CEO Carlos Riva, and CFO James Levine. Issues...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee